-

ValGenesis to Spotlight AI’s Expanding Role in Validation at Research Triangle Park Event

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in digital validation, will host the next event in its global ValConnect Innovation Day series on June 2 in North Carolina’s Research Triangle Park.

In addition to peer discussions and presentations, attendees will have the opportunity to see the ValGenesis iClean™ application, for digitalizing cleaning operations, demonstrated within Sequence’s mock pharmaceutical manufacturing facility.

Share

Hosted in partnership with Sequence Inc., at the company’s RTP headquarters, the one-day program will bring together life sciences professionals to explore AI-powered validation, digital transformation, and the evolving role of AI in modernizing validation processes across regulated environments.

Daniel R. Matlis, president of Axendia, will deliver the keynote address, “From Digital to Intelligent: The Next Era in Life Sciences.” Drawing on recent industry research, Matlis will examine how life sciences organizations are moving beyond digital transformation toward intelligence-driven operations that accelerate decision-making, reduce risk, and improve operational agility and compliance.

Sessions will explore practical applications of AI across validation and manufacturing operations, including cleaning validation, commissioning and qualification activities, and knowledge management. ValGenesis experts will also present a practical framework for evaluating AI autonomy in regulated environments, examining where AI should advise, assist, and act — and the governance considerations associated with each stage.

In addition to peer discussions and presentations, attendees will have the opportunity to see the ValGenesis iClean™ application, for digitalizing cleaning operations, demonstrated within Sequence’s mock pharmaceutical manufacturing facility.

“ValConnect Innovation Day brings together life sciences leaders to share practical experiences and explore how AI and digital transformation are shaping the future of validation,” said David Medina, chief marketing officer at ValGenesis. “These discussions help organizations better understand how to modernize validation processes while maintaining compliance and operational confidence.”

To view the full agenda and register, visit the ValGenesis events page.

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. For nearly two decades, ValGenesis has helped life sciences companies digitize commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ Platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers accelerate delivery, strengthen compliance, and improve operational efficiency across the product lifecycle. For more information, visit valgenesis.com.

Contacts

Media Contact for ValGenesis:
Lisa Weeks, 801-913-2686, lisa.weeks@valgenesis.com

ValGenesis, Inc.


Release Versions

Contacts

Media Contact for ValGenesis:
Lisa Weeks, 801-913-2686, lisa.weeks@valgenesis.com

Social Media Profiles
More News From ValGenesis, Inc.

Eugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSV

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in enterprise digital validation, announced that Eugia Pharmaceuticals, a global specialty pharmaceutical company, has gone live with ValGenesis to modernize computer system validation (CSV) processes across its sites in India. The deployment will help enhance compliance, improve operational efficiency, and support growth. Hyderabad-based Eugia Pharma, a subsidiary of Aurobindo Pharma, develops and markets complex generics. The...

ValGenesis to Host ValConnect Mumbai Focused on AI-Driven Validation

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in digital validation, will host ValConnect Innovation Day on Sept. 9 at the Hilton Mumbai International Airport, bringing together leaders from life sciences, technology, and manufacturing to examine the role of AI in validation, compliance, and quality across the GxP lifecycle. The one-day event, which concludes the 2026 ValConnect Innovation Day series, will focus on a central challenge facing life sciences organizations: how...

Leading Oncology Injectables Manufacturer Selects ValGenesis to Modernize Equipment Qualification

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in enterprise digital validation and compliance solutions, announced that a specialized Indian pharmaceutical joint venture focused on cytotoxic and oncology drug manufacturing, has selected the ValGenesis validation lifecycle management platform to modernize equipment qualification across its operations in India. The company manufactures injectable and sterile products for regulated global markets, operating state-of-the-...
Back to Newsroom